Taurine
Also sold as: Free taurine · 2-aminoethanesulfonic acid
A naturally occurring amino sulfonic acid involved in osmoregulation and cellular signaling. Supplements are studied for endurance and cardiometabolic markers; human lifespan extension is unproven.
Longevity
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Longevity: No human lifespan RCT is indexed in this dossier; animal lifespan findings do not establish a human benefit.
REALITY CHECK // Mouse lifespan extension of about 10-12% is not a human outcome. Human aging associations are inconsistent and no mortality/lifespan RCT resolves the claim. Caffeine-containing performance trials cannot isolate taurine, and sleep/anxiety claims rest mainly on mechanisms.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No numeric EFSA/NIH UL is supplied. A 2008 risk assessment proposed an observed safe level around 3 g/day supplemental taurine; OSL is not UL, NOAEL or evidence that higher doses are safe indefinitely.
Summary
A meta-analysis of ten studies suggests a small mainly acute endurance benefit. Blood-pressure and metabolic-marker trials show a favorable direction, but samples are small and do not establish longer life. Anxiety and sleep benefits lack convincing human RCT evidence.
Mechanism
Taurine contributes to osmoregulation, calcium handling and bile-acid conjugation. GABA/glycine receptor modulation is a proposed calming mechanism, not proof of treatment for anxiety or insomnia.
Typical studied dose
Endurance research summarized in the dossier used approximately 1-6 g, predominantly acute administration before exercise. Chronic cardiometabolic protocols differ. The 6 g trial range is not a routine-use target or safety ceiling.
Upper limit
No numeric EFSA/NIH UL is supplied. A 2008 risk assessment proposed an observed safe level around 3 g/day supplemental taurine; OSL is not UL, NOAEL or evidence that higher doses are safe indefinitely.
Popular stacks with Taurine
Not enough stack data yet. A combination with Taurine appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Free taurine powder Best for: Matching taurine-only endurance research |
100% elemental / active | 1000–6000 mg | Pure compound mass equals taurine mass; 100% is composition, not an absorption estimate. No proven efficacy advantage over capsules. Usually tolerated at studied amounts; individual gastrointestinal discomfort remains possible. |
Studied standard [FORM // TRIAL_REFERENCE] Pure compound mass equals taurine mass; 100% is composition, not an absorption estimate. No proven efficacy advantage over capsules. |
| Taurine capsules / tablets Best for: Convenient measured amount |
100% elemental / active | 1000–6000 mg | The same taurine molecule; compare declared taurine amount, not total tablet/excipient mass. No established superiority to powder. Usually tolerated at studied amounts; individual gastrointestinal discomfort remains possible. |
Good option [FORM // CHECK_LABEL] The same taurine molecule; compare declared taurine amount, not total tablet/excipient mass. No established superiority to powder. |
Common label traps
- TRAP_01 // TAURINE REVERSES HUMAN AGING
Animal lifespan findings are not human lifespan trials. - TRAP_02 // TAURINE IS THE STIMULANT IN ENERGY DRINKS
Caffeine and sugar confound the perceived effect; isolated taurine has only a small endurance signal. - TRAP_03 // MORE THAN 6 G IS REQUIRED
No megadose necessity is demonstrated. Trial doses and the 3 g/day OSL have different meanings.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- endurance Moderate · benefit
Ten-study meta-analysis, seven time-to-exhaustion studies: small benefit, mainly acute, with protocols around 1-6 g. It is not proof of more daily energy.
PMID 29546641 - blood-pressure Moderate · benefit
Seven-study meta-analysis, n=103: systolic Hedges g -0.70; diastolic pressure also lower. Small heterogeneous evidence base; later cardiovascular review supports the direction.
PMID 30006901 PMID 39148075 - metabolic-markers Moderate · benefit
RCT meta-analysis reports favorable blood-pressure, lipid and glycemic markers in adults with metabolic risk; surrogate changes do not establish mortality benefit.
PMID 38755142 - heart-failure Limited · benefit
Small, often old clinical studies suggest functional/exercise-capacity improvements in heart failure; clinical populations cannot establish healthy-adult energy benefits.
PMID 3888464 PMID 21334852 - animal-aging Anecdotal · benefit
Mouse lifespan increased about 10-12%, with animal health-marker benefits; human data are observational and inconsistent. No proven human longevity effect.
PMID 37289866 PMID 37289872 - exercise-damage Limited · benefit
One small young-adult trial found changes in damage/oxidation markers after eccentric exercise; functional recovery or muscle growth is not established.
PMID 24383513 - heat-exercise Limited · benefit
Small acute cycling trial suggests better thermoregulation/endurance in heat; a later review discusses mechanisms and limitations.
PMID 30776254 PMID 41754109 - sleep-and-anxiety No established evidence
Convincing human clinical RCT evidence is absent in this dossier. Receptor mechanisms cannot establish anxiolytic or sleep efficacy. - safety-assessment Limited · benefit
Risk assessment proposed supplemental observed safe level about 3 g/day; this is not a formal UL or license to megadose.
PMID 18325648
Reader questions
Powder or capsules?
The molecule is identical. Compare actual taurine content, cost and independent quality testing rather than presumed absorption differences.
Does it treat anxiety or insomnia?
Clinical benefit remains unproven in this dossier despite plausible receptor mechanisms. Persistent symptoms warrant assessment.
What if I develop chest pain after an energy drink?
Stop the product and seek prompt medical assessment; chest pain should not be attributed to taurine or managed by adding another supplement.
Stack interactions
- Caution Blood-pressure medication [CAUTION // CLINICAL_REVIEW]
Additive hypotension is plausible from taurine blood-pressure findings; direct clinical interaction studies are absent. Monitor with the treating clinician.
PMID 30006901 - Caution Glucose-lowering medication [CAUTION // CLINICAL_REVIEW]
Additive glucose lowering is theoretically possible from metabolic findings; a direct drug interaction is unverified.
PMID 38755142 - Caution Caffeine-containing energy drinks and pre-workouts [CAUTION // CLINICAL_REVIEW]
Much of the perceived stimulation may come from caffeine and sugar. Combination trials do not prove taurine-only effects; creatine/beta-alanine combinations lack a known conflict in the dossier.
Red flags: interactions and who should avoid it
Interactions
Additive hypotension is plausible from taurine blood-pressure findings; direct clinical interaction studies are absent. Monitor with the treating clinician. Additive glucose lowering is theoretically possible from metabolic findings; a direct drug interaction is unverified. Much of the perceived stimulation may come from caffeine and sugar. Combination trials do not prove taurine-only effects; creatine/beta-alanine combinations lack a known conflict in the dossier.
Avoid or ask a doctor first if
High supplement amounts in pregnancy/breastfeeding and severe kidney failure lack adequate safety data. Seek review for low blood pressure, diabetes medication or psychiatric illness. Energy-drink adverse reports are confounded by caffeine and other ingredients; they cannot establish taurine-specific causation.
Sources (PubMed, 12)
- The Effects of an Oral Taurine Dose and Supplementation Period on Endurance Exercise Performance in Humans: A Meta-Analysis.
PMID 29546641 · 2018 · systematic review/meta-analysisTen-study meta-analysis, seven time-to-exhaustion studies: small benefit, mainly acute, with protocols around 1-6 g. It is not proof of more daily energy.
- The Effects of Oral Taurine on Resting Blood Pressure in Humans: a Meta-Analysis.
PMID 30006901 · 2018 · systematic review/meta-analysisSeven-study meta-analysis, n=103: systolic Hedges g -0.70; diastolic pressure also lower. Small heterogeneous evidence base; later cardiovascular review supports the direction.
- Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis.
PMID 39148075 · 2024 · systematic review/meta-analysisSeven-study meta-analysis, n=103: systolic Hedges g -0.70; diastolic pressure also lower. Small heterogeneous evidence base; later cardiovascular review supports the direction.
- Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
PMID 38755142 · 2024 · systematic review/meta-analysisRCT meta-analysis reports favorable blood-pressure, lipid and glycemic markers in adults with metabolic risk; surrogate changes do not establish mortality benefit.
- Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
PMID 3888464 · 1985 · randomized controlled trialSmall, often old clinical studies suggest functional/exercise-capacity improvements in heart failure; clinical populations cannot establish healthy-adult energy benefits.
- Effect of taurine supplementation on exercise capacity of patients with heart failure.
PMID 21334852 · 2011 · randomized controlled trialSmall, often old clinical studies suggest functional/exercise-capacity improvements in heart failure; clinical populations cannot establish healthy-adult energy benefits.
- Taurine deficiency as a driver of aging.
PMID 37289866 · 2023 · animal studyMouse lifespan increased about 10-12%, with animal health-marker benefits; human data are observational and inconsistent. No proven human longevity effect.
- Taurine linked with healthy aging.
PMID 37289872 · 2023 · animal studyMouse lifespan increased about 10-12%, with animal health-marker benefits; human data are observational and inconsistent. No proven human longevity effect.
- Effects of taurine supplementation following eccentric exercise in young adults.
PMID 24383513 · 2014 · randomized controlled trialOne small young-adult trial found changes in damage/oxidation markers after eccentric exercise; functional recovery or muscle growth is not established.
- Acute taurine supplementation enhances thermoregulation and endurance cycling performance in the heat.
PMID 30776254 · 2019 · randomized controlled trialSmall acute cycling trial suggests better thermoregulation/endurance in heat; a later review discusses mechanisms and limitations.
- Taurine Supplementation and Human Heat Tolerance: Mechanisms, Evidence, and Integration with Heat Acclimation, Cooling, and Hydration.
PMID 41754109 · 2026 · narrative reviewSmall acute cycling trial suggests better thermoregulation/endurance in heat; a later review discusses mechanisms and limitations.
- Risk assessment for the amino acids taurine, L-glutamine and L-arginine.
PMID 18325648 · 2008 · narrative reviewRisk assessment proposed supplemental observed safe level about 3 g/day; this is not a formal UL or license to megadose.
Community comments
No approved comments yet. Comments are held for moderation.